Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker AnalysesJung Min Lee, Elise C. Kohn, John L. Hays et al.|JNCI Journal of the National Cancer Institute|2014Cited by 184
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in miceKevin M. Huang, Alex Sparreboom, Alix F. Leblanc et al.|Journal of Clinical Investigation|2020Cited by 69
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, Craig Vargo, M. Alexandra Schickli et al.|Clinical Breast Cancer|2019Cited by 47
Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivorsAllison Quick, Maryam B. Lustberg, Bhuvaneswari Ramaswamy et al.|Supportive Care in Cancer|2019Cited by 43
Worry and rumination in breast cancer patients: perseveration worsens self-rated healthMegan E. Renna, Janice K. Kiecolt‐Glaser, M. Rosie Shrout et al.|Journal of Behavioral Medicine|2020Cited by 41